Gene · 7357
Papers2,116
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,116
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets. | Front Oncol | 2022 | 35756630 | PubTator, text mining | PubMed |
| Involvement of Ceramide Signalling in Radiation-Induced Tumour Vascular Effects and Vascular-Targeted Therapy. | Int J Mol Sci | 2022 | 35743121 | PubTator, text mining | PubMed |
| Biofluid Metabolomics and Lipidomics of Mice Exposed to External Very High-Dose Rate Radiation. | Metabolites | 2022 | 35736453 | PubTator, text mining | PubMed |
| Clinical Characteristics, Renal Involvement, and Therapeutic Options of Pediatric Patients With Fabry Disease. | Front Pediatr | 2022 | 35722479 | PubTator, text mining | PubMed |
| Insulin-inducible THRSP maintains mitochondrial function and regulates sphingolipid metabolism in human adipocytes. | Mol Med | 2022 | 35715726 | PubTator, text mining | PubMed |
| Recent insights into the effects of metabolism on breast cancer cell dormancy. | Br J Cancer | 2022 | 35715635 | PubTator, text mining | PubMed |
| Disease modification in Parkinsonism: obstacles and ways forward. | J Neural Transm (Vienna) | 2022 | 35695938 | PubTator, text mining | PubMed |
| Regulation of the lysosome by sphingolipids: Potential role in aging. | J Biol Chem | 2022 | 35691340 | PubTator, text mining | PubMed |
| Interaction between Bacteria and the Immune System for Cancer Immunotherapy: The α-GalCer Alliance. | Int J Mol Sci | 2022 | 35682578 | PubTator, text mining | PubMed |
| Recommendations for oral treatment for adult patients with type 1 Gaucher disease. | Rev Clin Esp (Barc) | 2022 | 35676195 | PubTator, text mining | PubMed |
| High-throughput metabolomics reveals dysregulation of hydrophobic metabolomes in cancer cell lines by Eleusine indica. | Sci Rep | 2022 | 35668092 | PubTator, text mining | PubMed |
| Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease. | Sci Rep | 2022 | 35660779 | PubTator, text mining | PubMed |
| Modeling Nonischemic Genetic Cardiomyopathies Using Induced Pluripotent Stem Cells. | Curr Cardiol Rep | 2022 | 35657495 | PubTator, text mining | PubMed |
| Bioinformatics Study Identified EGF as a Crucial Gene in Papillary Renal Cell Cancer. | Dis Markers | 2022 | 35655917 | PubTator, text mining | PubMed |
| Orphan Drug Use in Patients With Rare Diseases: A Population-Based Cohort Study. | Front Pharmacol | 2022 | 35652051 | PubTator, text mining | PubMed |
| GBA1-dependent membrane glucosylceramide reprogramming promotes liver cancer metastasis via activation of the Wnt/β-catenin signalling pathway. | Cell Death Dis | 2022 | 35637196 | PubTator, text mining | PubMed |
| Persistent Properties of a Subpopulation of Cancer Cells Overexpressing the Hedgehog Receptor Patched. | Pharmaceutics | 2022 | 35631574 | PubTator, text mining | PubMed |
| Skeletal Muscle and COVID-19: The Potential Involvement of Bioactive Sphingolipids. | Biomedicines | 2022 | 35625805 | PubTator, text mining | PubMed |
| Repurposing drugs to treat cardiovascular disease in the era of precision medicine. | Nat Rev Cardiol | 2022 | 35606425 | PubTator, text mining | PubMed |
| Gastric cancer biomarker analysis in patients treated with different adjuvant chemotherapy regimens within SAMIT, a phase III randomized controlled trial. | Sci Rep | 2022 | 35595817 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7357/papers?page=20